We are thrilled that our project addressing the role of B-cells in breast tumor invasion has been funded by the South-Eastern Norway Regional Health Authority. Looking forward to working three more years with DCIS and breast tumor invasion, this time with even more focus on the immune mechanisms of invasion.
This week, Jens Henrik Norum and Helga Bergholtz are in San Diego to present their work on spatial transcriptomics of ductal carcinoma in situ on the AACR Advances in Breast Cancer Research conference. They will present their poster titled “Spatial transcriptomics of ductal carcinoma in situ reveal subtype specific differences in tumoral and stromal cell compartments” and have also been selected for holding a short talk.
Cand. med. Hedda von der Lippe Gythfeldt has succesfully defended her thesis: "Identifying molecular factors responsible for treatment response and resistance in a breast cancer study and a breast cancer model" for the degree of PhD at Institute for Clinical Medicine, University of Oslo. We are very proud and happy for her achievement!
Our group has received funding from the Norwegian Cancer Society for a new project on DCIS: "Spatial heterogeneity and breast cancer lineages in Ductal Carcinoma In Situ". Read more here (in Norwegian).
